Image

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Comparing Ticagrelor and Cilostazol for Large-Vessel Stroke Treatment.

Recruiting
18-75 years
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study compares two medicines, *ticagrelor* and *cilostazol*, used to treat large-vessel ischemic stroke, which happens when a blood clot blocks blood flow to the brain. The study takes place at Kafr el-Sheikh University and lasts from December 2022 to February 2024. Participants receive either ticagrelor or cilostazol and are monitored for 90 days. The study measures how well the medicines prevent new strokes and any side effects. The NIHSS (National Institutes of Health Stroke Scale) and mRS (Modified Rankin Scale) are tools used to check stroke severity and recovery.

  • The study lasts 3 months and involves multiple visits for check-ups and tests like MRI and CT scans.
  • Participants must be aged 18-75, have their first large-vessel ischemic stroke, and receive treatment within 24 hours.
  • Risks include potential drug side effects and requirements to avoid certain medications and conditions.
Print
Study details
    Ischemic Stroke

NCT06202755

Kafrelsheikh University

14 June 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.